Search PubMedSearch

Biomedical subjects

S Heinzl

Publications and source records attributed to S Heinzl.

At least 19 recordsLinked to original sources

[Comparative DNA hybridization, cytology and histology of condylomatous and precancerous lesions of the cervix uteri].

Cell scrapings from 552 consecutive women attending the colposcopy outpatient unit were examined by radioactive isotopic DNA hybridisation using the Dot-Blot technique, and by conventional Papanicolaou-smear cytology. In 315 out of these patients, punch biopsies were submitted for histological examination. HPV DNA-sequences were detected in 72% (n = 167) of 232 cytologically diagnosed CIN cases and in 77% (n = 97) out of 126 histological diagnoses of CIN. The proportion of HPV positive cases increased proportionally to the grade of CIN. The frequency of HPV type 6/11 decreased proportionally to the grade of the CIN, and HPV type 16/18 increased at the same time. The most frequent HPV type was 16/18 (26.3%), followed by the HPV types 31/33/35 (16.3%) and 6/11 (4.2%). Furthermore, HPV positivity was detected in 16.5% of patients with negative cytologic smears, in 21.7% of those with negative histology and in 8.9% of women with both negative histology and cytology. Histological and moreover cytological criteria of HPV infection decreased dramatically and proportionally inverse to the grade of the CIN. These changes were not followed entirely by HPV positivity. The discrepancy between HPV positivity (66.1%/67.6%) and morphological evidence of HPV infection (cytology 4.9%, histology 21.6%) was higher in CIN III than in lower grade CIN. Neither cytology nor histology is able to detect all HPV-related cervical lesions. Hybridisation techniques are helpful in the detection of latent HPV infections as well as of CIN lesions have been missed either by cytology or by histology or both. Thus both morphological methods are supplemented by HPV hybridisation.(ABSTRACT TRUNCATED AT 250 WORDS)

Cervix Uteri

[Target enzyme].

Explore the source record for details and available documents.

5-alpha Reductase Inhibitors

[Our sources].

Explore the source record for details and available documents.

Education, Pharmacy, Continuing

[Dysmenorrhea].

Explore the source record for details and available documents.

Dysmenorrhea

[Routine screening for Chlamydia: is it sensible during pregnancy?].

610 pregnant patients were examined for evidence of Chlamydia trachomatis infection. Chlamydia trachomatis could be detected in 18 of these 610 patients. This results in a low prevalence rate of 3%; therefore, screening for Chlamydia trachomatis is not indicated in our pregnant population. Among the 18 chlamydia-positive patients we could not discover any risk factors that were associated with this infection. Because of the varied and sometimes silent course in affected patients, this special investigation should be used liberally in a variety of situations.

Adult

[Preventive procedures in women at the University Women's Clinic in Basel].

The technique for obtaining a cytological cervical smear using Papanicolaou's stain ("Pap smear") is an established screening procedure. Discussion centres on the ideal intervals for smear test repetition and the age groups to be included in screening programmes. The effective interval and age breakdown were therefore studied in the patient population seen by us at the University Gynaecology Clinic in Basel. It was found that predominantly younger women took part in screening programmes. Fifty percent of the women had two smear tests within 18 months. It was also found that the interval between smear tests increased as patients grew older. With the recommendation of an annual smear test, screening in Basel covers 37% of women in one year and 76% in three years. Results in private patients are more favourable. In the light of these data, an annual smear test should continue to be recommended in all circumstances.

Adolescent

[Septic abortion].

Explore the source record for details and available documents.

Abortion, Septic

[New drugs].

Explore the source record for details and available documents.

Drug Compounding